| 11/14/2025 14:00 |
Notice Regarding Consolidated Subsidiary (MEDLEAP PHARMA COMPANY LIMITED) Notice Regarding the Initiation of Phase 2 Clinical Trial in Japan for Ferri |
| 11/14/2025 14:00 |
Notice Regarding Recording of Non-Operating Income and Notice Regarding Recording of Gain on Sales of Investment Securities (Extraordinary Income) Par |
| 11/14/2025 14:00 |
Notice Regarding Revision of Consolidated Financial Forecasts for Fiscal Year 2025 |
| 11/14/2025 14:00 |
Consolidated Financial Statements for the Second Quarter of the Fiscal Year Ending March 31, 2026 [Japanese GAAP] |
| 09/26/2025 16:00 |
Disclosure of Subsidiary Company Name |
| 08/29/2025 15:00 |
Notice Regarding Establishment of a Subsidiary |
| 08/06/2025 14:00 |
Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2026 [Japanese GAAP] |
| 07/28/2025 15:00 |
Notice Regarding Recording of Gain on Sale of Investment Securities (Extraordinary Income) |
| 07/25/2025 15:30 |
[Summary]Notice Regarding Completion of Payment for Disposal of Treasury Stockas Restricted Stock and Partial Forfeiture |
| 07/01/2025 12:30 |
[Updated]Notice Regarding Disposition of Treasury Stock for Performance-Linked Restricted Stock Compensation |
| 07/01/2025 12:30 |
[Updated]Notice of Change of Directors and Other Personnel in the Group |
| 06/26/2025 14:00 |
[Summary]Notice of Changes in Directors and Personnel of our Group |
| 06/26/2025 14:00 |
[Summary]Notice Regarding Disposition of Treasury Stock for Performance-Linked Restricted Stock Compensation |
| 06/03/2025 08:00 |
NOTICE OF THE 16TH ANNUAL GENERAL MEETING OF SHAREHOLDERS |
| 05/22/2025 12:30 |
[Updated]Partial Revision of the Performance-Linked Restricted Stock Compensation Plan |
| 05/22/2025 12:30 |
[Updated]Notice of Organizational Changes, Change of Representative Director, Directors and Other Personnel |
| 05/21/2025 11:30 |
[Updated]Notice of Partial Amendments to the Articles of Incorporation |
| 05/14/2025 14:00 |
[Summary]Notice Regarding Disposition of Treasury Stock for Performance-Linked Restricted Stock Compensation |
| 05/14/2025 14:00 |
Notice of Dividend of Surplus |
| 05/14/2025 14:00 |
[Summary]Notice Regarding Partial Amendment to Performance-Linked Restricted Stock Compensation Plan |
| 05/14/2025 14:00 |
[Summary]Notice of Partial Amendments to the Articles of Incorporation |
| 05/14/2025 14:00 |
[Summary]Notice of organizational changes, changes in representative directors, changes in directors, and changes in personnel assignments |
| 05/14/2025 14:00 |
Consolidated Financial Statements for the Fiscal Year Ended March 31, 2025 [Japanese GAAP] |
| 05/01/2025 14:30 |
[Updated]Notice Regarding the Medium-Term Management Plan 2027 - Move on to the Next Stage - |
| 04/17/2025 15:20 |
[Summary]Notice Regarding the Medium-Term Management Plan 2027 - Move on to the Next Stage - |
| 02/25/2025 15:30 |
Notice of Revision of Earnings Forecast and Year-End Dividend Forecast (Dividend Increase) for Fiscal Year Ending March 31 2025 |
| 02/25/2025 11:00 |
[Delayed] Notice Regarding Change in Largest Shareholder and Acquisition of Shares Defined by Government Ordinance as an Act Equivalent to a Tender Of |
| 02/12/2025 14:00 |
Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2025 (the 16th term) |
| 02/12/2025 14:00 |
Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] |
| 12/27/2024 13:00 |
Notice Regarding Recording of Gain on Sale of Investment Securities (Extraordinary Income) |
| 12/26/2024 13:00 |
[Delayed] Notice Regarding Changes in Large and Largest Shareholders |
